Skip to main content

Lucid Diagnostics Inc.

LUCD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001799011

No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Lucid Diagnostics Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of LUCD: Q3 2023 compared with Q4 2023
MeasureQ3 2023Of which not filed for Q4 2023Q4 2023Change
Holders24125+2
Shares1.92M73.9K1.75M−93.9K (−5.1%)
Value$2.24M$86.5K$2.46M+$309.8K (+14.4%)

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Lucid Diagnostics Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to LUCD in Q4 2023
InstitutionSharesValue% of portfolio
Virtu Financial LLC20,836$29.0K0.00%
Advisory Services Network, LLC765$1.08K0.00%
Royal Bank of Canada198$00.00%

Sold out (1)

Institutions that held Lucid Diagnostics Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of LUCD in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
CWM, LLC1,920$2.00K

Not filed for Q4 2023 yet (1)

Institutions that held Lucid Diagnostics Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LUCD in Q3 2023 that haven't filed for Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Ayrton Capital LLC73,907$86.5K